313 related articles for article (PubMed ID: 24370689)
21. Predictive factors from cold knife conization for residual cervical intraepithelial neoplasia in subsequent hysterectomy.
Moore BC; Higgins RV; Laurent SL; Marroum MC; Bellitt P
Am J Obstet Gynecol; 1995 Aug; 173(2):361-6; discussion 366-8. PubMed ID: 7645609
[TBL] [Abstract][Full Text] [Related]
22. Prospective management of stage IA(1) cervical adenocarcinoma by conization alone to preserve fertility: a preliminary report.
Schorge JO; Lee KR; Sheets EE
Gynecol Oncol; 2000 Aug; 78(2):217-20. PubMed ID: 10926806
[TBL] [Abstract][Full Text] [Related]
23. Management of adenocarcinoma in situ of the uterine cervix: a comparison of loop electrosurgical excision procedure and cold knife conization.
Latif NA; Neubauer NL; Helenowski IB; Lurain JR
J Low Genit Tract Dis; 2015 Apr; 19(2):97-102. PubMed ID: 25089550
[TBL] [Abstract][Full Text] [Related]
24. Recurrent invasive adenocarcinoma after hysterectomy for cervical adenocarcinoma in situ.
Krivak TC; Retherford B; Voskuil S; Rose GS; Alagoz T
Gynecol Oncol; 2000 May; 77(2):334-5. PubMed ID: 10785491
[TBL] [Abstract][Full Text] [Related]
25. Residual disease and presence of human papillomavirus after conization.
Kanamori Y; Kigawa J; Minagawa Y; Irie T; Oishi T; Itamochi H; Cheng X; Terakawa N
Oncology; 1998; 55(6):517-20. PubMed ID: 9778616
[TBL] [Abstract][Full Text] [Related]
26. Fertility-sparing treatment in younger women with adenocarcinoma in situ of the cervix.
van Hanegem N; Barroilhet LM; Nucci MR; Bernstein M; Feldman S
Gynecol Oncol; 2012 Jan; 124(1):72-7. PubMed ID: 22030403
[TBL] [Abstract][Full Text] [Related]
27. Risk of residual disease and invasive carcinoma in women treated for adenocarcinoma in situ of the cervix.
Costales AB; Milbourne AM; Rhodes HE; Munsell MF; Wallbillich JJ; Brown J; Frumovitz M; Ramondetta LM; Schmeler KM
Gynecol Oncol; 2013 Jun; 129(3):513-6. PubMed ID: 23541795
[TBL] [Abstract][Full Text] [Related]
28. Management of patients with positive margins after cervical conization.
Lapaquette TK; Dinh TV; Hannigan EV; Doherty MG; Yandell RB; Buchanan VS
Obstet Gynecol; 1993 Sep; 82(3):440-3. PubMed ID: 8355949
[TBL] [Abstract][Full Text] [Related]
29. Predictive value of cone margins and post-cone endocervical curettage with residual disease in subsequent hysterectomy.
Husseinzadeh N; Shbaro I; Wesseler T
Gynecol Oncol; 1989 May; 33(2):198-200. PubMed ID: 2703181
[TBL] [Abstract][Full Text] [Related]
30. Conservative management of adenocarcinoma in situ of the cervix.
Shin CH; Schorge JO; Lee KR; Sheets EE
Gynecol Oncol; 2000 Oct; 79(1):6-10. PubMed ID: 11006022
[TBL] [Abstract][Full Text] [Related]
31. Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases.
Ostör AG; Duncan A; Quinn M; Rome R
Gynecol Oncol; 2000 Nov; 79(2):207-10. PubMed ID: 11063645
[TBL] [Abstract][Full Text] [Related]
32. Comparison of cold knife cone biopsy and loop electrosurgical excision procedure in the management of cervical adenocarcinoma in situ: What is the gold standard?
Munro A; Leung Y; Spilsbury K; Stewart CJ; Semmens J; Codde J; Williams V; O'Leary P; Steel N; Cohen P
Gynecol Oncol; 2015 May; 137(2):258-63. PubMed ID: 25769659
[TBL] [Abstract][Full Text] [Related]
33. Fertility sparing treatment for in situ and early invasive adenocarcinoma of the cervix.
McHale MT; Le TD; Burger RA; Gu M; Rutgers JL; Monk BJ
Obstet Gynecol; 2001 Nov; 98(5 Pt 1):726-31. PubMed ID: 11704160
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathologic features of early adenocarcinoma of the cervix initially managed with cervical conization.
Poynor EA; Marshall D; Sonoda Y; Slomovitz BM; Barakat RR; Soslow RA
Gynecol Oncol; 2006 Dec; 103(3):960-5. PubMed ID: 16860853
[TBL] [Abstract][Full Text] [Related]
35. Fertility-sparing surgery in 101 women with adenocarcinoma in situ of the cervix.
Bull-Phelps SL; Garner EI; Walsh CS; Gehrig PA; Miller DS; Schorge JO
Gynecol Oncol; 2007 Nov; 107(2):316-9. PubMed ID: 17689593
[TBL] [Abstract][Full Text] [Related]
36. Risk of residual invasive disease in women with microinvasive squamous cancer in a conization specimen.
Roman LD; Felix JC; Muderspach LI; Agahjanian A; Qian D; Morrow CP
Obstet Gynecol; 1997 Nov; 90(5):759-64. PubMed ID: 9351760
[TBL] [Abstract][Full Text] [Related]
37. Value of human papillomavirus deoxyribonucleic acid testing after conization in the prediction of residual disease in the subsequent hysterectomy specimen.
Lin CT; Tseng CJ; Lai CH; Hsueh S; Huang KG; Huang HJ; Chao A
Am J Obstet Gynecol; 2001 Apr; 184(5):940-5. PubMed ID: 11303202
[TBL] [Abstract][Full Text] [Related]
38. The role of endocervical curettage at cervical conization for high-grade dysplasia.
Kobak WH; Roman LD; Felix JC; Muderspach LI; Schlaerth JB; Morrow CP
Obstet Gynecol; 1995 Feb; 85(2):197-201. PubMed ID: 7824230
[TBL] [Abstract][Full Text] [Related]
39. Cervical adenocarcinoma in situ: the predictive value of conization margin status.
Young JL; Jazaeri AA; Lachance JA; Stoler MH; Irvin WP; Rice LW; Andersen WA; Modesitt SC
Am J Obstet Gynecol; 2007 Aug; 197(2):195.e1-7; discussion 195.e7-8. PubMed ID: 17689647
[TBL] [Abstract][Full Text] [Related]
40. Predicting persistent/recurrent disease in the cervix after excisional biopsy.
Ramchandani SM; Houck KL; Hernandez E; Gaughan JP
MedGenMed; 2007 Apr; 9(2):24. PubMed ID: 17955080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
